Connect your AI

Biodesix, Inc. BDSX Intangibles (Net)

Intangibles (Net) at other companies

NeoGenomicsNEO

$265.45M-16.5%

VeracyteVCYT

$79.66M-6.9%

Adaptive BiotechnologiesADPT

$1.31M-56.5%

Guardant HealthGH

$4.71M-25.0%

GeneDx HoldingsWGS

$144.97M-6.5%

Tempus AI, Inc.TEM

——

Other financials

Income statement

Revenue$25.6M+42.3%

Operating income-$6.2M+32.1%

Net income-$7.8M+29.8%

EPS (diluted)-$0.81+46.7%

Balance sheet

Cash & equivalents$25.6M+45.3%

Total debt$71.6M+15.0%

Total equity$9.1M-17.4%

Total assets$94.6M+9.7%

Cash flow

Operating cash flow-$10.2M-18.2%

CapEx$81.0K+9.5%

Free cash flow-$10.2M-18.1%

Valuation

Market cap$233.52M+462%

Enterprise value$279.56M+198%

P/S2.4×+1.9×

Profitability

Operating margin-26%-7.5pp

Net margin-33.3%-9.3pp

FCF margin-26.8%-9.6pp

Returns & leverage

Return on equity-316.5%—

Debt / equity7.8×+2.2×

Current ratio2.8×+0.6×

Where this comes from

Reported directly by Biodesix, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IntangibleAssetsNetExcludingGoodwill.

The official record: Biodesix, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biodesix, Inc.'s intangibles (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Biodesix, Inc.'s intangibles (net)?: Biodesix, Inc. (BDSX) reported intangibles (net) of $3.45M in Q1 2026.
How has Biodesix, Inc.'s intangibles (net) changed year-over-year?: Biodesix, Inc.'s intangibles (net) decreased by 35.6% year-over-year, from $5.36M to $3.45M.
What is the long-term trend for Biodesix, Inc.'s intangibles (net)?: Over 5 years (2020 to 2025), Biodesix, Inc.'s intangibles (net) has grown at a -21.8% compound annual growth rate (CAGR), from $13.26M to $3.88M.
What does intangibles (net) mean?: Identifiable intangible assets (patents, trademarks, customer relationships, technology) net of accumulated amortization — excluding goodwill.